These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 16205037)

  • 61. Fluconazole but not itraconazole decreases the metabolism of losartan to E-3174.
    Kaukonen KM; Olkkola KT; Neuvonen PJ
    Eur J Clin Pharmacol; 1998 Feb; 53(6):445-9. PubMed ID: 9551703
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Antifungal susceptibility of epigallocatechin 3-O-gallate (EGCg) on clinical isolates of pathogenic yeasts.
    Park BJ; Park JC; Taguchi H; Fukushima K; Hyon SH; Takatori K
    Biochem Biophys Res Commun; 2006 Aug; 347(2):401-5. PubMed ID: 16831406
    [TBL] [Abstract][Full Text] [Related]  

  • 63. In vitro antifungal activity of a novel lipopeptide antifungal agent, FK463, against various fungal pathogens.
    Uchida K; Nishiyama Y; Yokota N; Yamaguchi H
    J Antibiot (Tokyo); 2000 Oct; 53(10):1175-81. PubMed ID: 11132964
    [TBL] [Abstract][Full Text] [Related]  

  • 64. In vitro activity of fluconazole, voriconazole and caspofungin against clinical yeast isolates.
    Maida CM; Milici ME; Oliveri S
    J Chemother; 2007 Jun; 19(3):277-82. PubMed ID: 17594922
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Optimizing higher throughput methods to assess drug-drug interactions for CYP1A2, CYP2C9, CYP2C19, CYP2D6, rCYP2D6, and CYP3A4 in vitro using a single point IC(50).
    Gao F; Johnson DL; Ekins S; Janiszewski J; Kelly KG; Meyer RD; West M
    J Biomol Screen; 2002 Aug; 7(4):373-82. PubMed ID: 12230892
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of the growth medium on the in vitro antifungal activity of micafungin (FK-463) against clinical isolates of Candida dubliniensis.
    Müller FM; Kurzai O; Hacker J; Frosch M; Mühlschlegel F
    J Antimicrob Chemother; 2001 Nov; 48(5):713-5. PubMed ID: 11679561
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Induction potential of antifungals containing an imidazole or triazole moiety. Miconazole and ketoconazole, but not itraconazole are able to induce hepatic drug metabolizing enzymes of male rats at high doses.
    Lavrijsen K; Van Houdt J; Thijs D; Meuldermans W; Heykants J
    Biochem Pharmacol; 1986 Jun; 35(11):1867-78. PubMed ID: 3013201
    [TBL] [Abstract][Full Text] [Related]  

  • 68. In vitro antifungal susceptibility of Malassezia pachydermatis from dogs with and without skin lesions.
    Cafarchia C; Figueredo LA; Iatta R; Montagna MT; Otranto D
    Vet Microbiol; 2012 Mar; 155(2-4):395-8. PubMed ID: 21962411
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Newer antifungal agents micafungin and voriconazole for fungal infection prevention during hematopoietic cell transplantation: a meta-analysis.
    Xu SX; Shen JL; Tang XF; Feng B; Xu HQ
    Eur Rev Med Pharmacol Sci; 2016; 20(2):381-90. PubMed ID: 26875911
    [TBL] [Abstract][Full Text] [Related]  

  • 70. In vitro interaction of micafungin and fluconazole against Candida.
    Rodríguez MM; Ruiz M; Pastor FJ; Quindós G; Carrillo A; Guarro J
    J Antimicrob Chemother; 2007 Jul; 60(1):188-90. PubMed ID: 17525050
    [No Abstract]   [Full Text] [Related]  

  • 71. Prediction of the metabolic interaction of nateglinide with other drugs based on in vitro studies.
    Takanohashi T; Koizumi T; Mihara R; Okudaira K
    Drug Metab Pharmacokinet; 2007 Dec; 22(6):409-18. PubMed ID: 18159128
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Concomitant tacrolimus and micafungin pharmacokinetics in healthy volunteers.
    Hebert MF; Blough DK; Townsend RW; Allison M; Buell D; Keirns J; Bekersky I
    J Clin Pharmacol; 2005 Sep; 45(9):1018-24. PubMed ID: 16100295
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pharmacokinetics and pharmacodynamics of antifungals in children and their clinical implications.
    Stockmann C; Constance JE; Roberts JK; Olson J; Doby EH; Ampofo K; Stiers J; Spigarelli MG; Sherwin CM
    Clin Pharmacokinet; 2014 May; 53(5):429-54. PubMed ID: 24595533
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.
    Messer SA; Diekema DJ; Boyken L; Tendolkar S; Hollis RJ; Pfaller MA
    J Clin Microbiol; 2006 Feb; 44(2):324-6. PubMed ID: 16455878
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Micafungin sodium (FK-463).
    Fromtling RA
    Drugs Today (Barc); 2002 Apr; 38(4):245-57. PubMed ID: 12532193
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Predicting the Effects of Different Triazole Antifungal Agents on the Pharmacokinetics of Tamoxifen.
    Chen L; Zhu L; Li M; Li N; Qi F; Wang N
    AAPS PharmSciTech; 2019 Jan; 20(1):24. PubMed ID: 30604153
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The enzymatic basis of drug-drug interactions with systemic triazole antifungals.
    Nivoix Y; Levêque D; Herbrecht R; Koffel JC; Beretz L; Ubeaud-Sequier G
    Clin Pharmacokinet; 2008; 47(12):779-92. PubMed ID: 19026034
    [TBL] [Abstract][Full Text] [Related]  

  • 78. In vitro hepatic metabolism explains higher clearance of voriconazole in children versus adults: role of CYP2C19 and flavin-containing monooxygenase 3.
    Yanni SB; Annaert PP; Augustijns P; Ibrahim JG; Benjamin DK; Thakker DR
    Drug Metab Dispos; 2010 Jan; 38(1):25-31. PubMed ID: 19841059
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of Fluconazole and Itraconazole on the Pharmacokinetics of Erdafitinib in Healthy Adults: A Randomized, Open-Label, Drug-Drug Interaction Study.
    Poggesi I; Li LY; Jiao J; Hellemans P; Rasschaert F; de Zwart L; Snoeys J; De Meulder M; Mamidi RNVS; Ouellet D
    Eur J Drug Metab Pharmacokinet; 2020 Feb; 45(1):101-111. PubMed ID: 31673875
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Coadministration of voriconazole and phenytoin: pharmacokinetic interaction, safety, and toleration.
    Purkins L; Wood N; Ghahramani P; Love ER; Eve MD; Fielding A
    Br J Clin Pharmacol; 2003 Dec; 56 Suppl 1(Suppl 1):37-44. PubMed ID: 14616412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.